Keep my session open?
Ending In 
The session is expired
Your session has expired. For your security, we have logged you out.
Would you like to log in again?

Update to Avantor’s response to the coronavirus (COVID-19) pandemic

  • Product Results
  • Supplier
    • Refine by Suppliers
    Sort by:
    Close

  • Search Within Results


SearchPresentationType-HORIZONTAL
Choose from the options below to refine your search. Click OK to update your results.
 
 
 
SearchResultCount:"1"
Searching List View List View BETA(new) 
Sort by:
 
 
 
 

Image Unavailable
Description:   Bupivacaine is a sodium channel blocker, local anesthetic. It binds to the intracellular portion of sodium channels and blocks sodium influx into nerve cells, which prevents depolarization. Since pain transmitting nerve fibres tend to be thinner and either unmyelinated or lightly myelinated, the agent can diffuse more readily into them than into thicker and more heavily myelinated nerve fibres like touch, proprioception, etc. (Myelin is non-polar / lipophilic). It should be noted, however, that bupivacaine also blocks specific potassium channels, an effect contributing to resting membrane potential depolarization.
Catalog Number: IC15490405
Supplier: MP Biomedicals



Quantity:
 
 
 
MSDS SDS Certificate Certificates    
1 - 1  of 1